image
Healthcare - Biotechnology - NASDAQ - US
$ 8.69
-3.55 %
$ 1.01 B
Market Cap
-6.12
P/E
INCOME STATEMENT
9.99 M REVENUE
0.00%
-64.5 M OPERATING INCOME
22.20%
-120 M NET INCOME
-45.15%
EFFICIENCY
Earnings Waterfall Applied Therapeutics, Inc.
image
Revenue 9.99 M
Cost Of Revenue 53.9 M
Gross Profit -43.9 M
Operating Expenses 74.2 M
Operating Income -64.5 M
Other Expenses 55.2 M
Net Income -120 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
REVENUE
Revenue 10.0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 53.9 0.4 0.4 0.4 23 K 0 0
Gross Profit (43.9) (0.4) (0.4) (0.4) 23 K 0 0
OPERATING INCOME
Operating Expenses 74.2 83.0 105.6 94.5 45.6 13.5 4.3
Selling, General and Administrative Expenses 20.6 27.3 43.0 32.7 13.2 2.0 0.6
Research and Development Expenses 53.9 55.6 62.6 61.8 32.4 11.5 3.7
Operating Income (64.5) (83.0) (105.6) (94.5) (45.6) (13.5) (4.3)
PRE-TAX INCOME
Interest Income Expense 0 (0.4) 0.6 0.6 93 K 0 0
Total Other Income (55.2) 0.4 34 K 0.5 69 K (3.0) 3 K
Pre-Tax Income (119.8) (82.5) (105.6) (94.0) (45.5) (16.5) (4.3)
NET INCOME
Tax Provision 0 (0.8) (1.0) (0.9) (0.1) 4.9 (4.3)
Net Income (119.8) (81.7) (104.6) (93.0) (45.4) (16.5) (4.3)
EPS 1.42 2.16 4.09 4.23 3.54 1.8 0.47